반응 #44175

ord-331648d55fa94256b6a3643d83c4757a

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    농축then concentrated under vacuum
  2. 2
    세척eluted with methanol
  3. 3
    농축The combined basic fractions were concentrated under vacuum
  4. 4
    workup.DISSOLUTIONThe residue, (10 mg) was then dissolved in DCM (1 mL)
  5. 5
    workup.STIRRINGThe mixture was stirred for 1 h
  6. 6
    농축then concentrated under vacuum
  7. 7
    기타purified by preparative mass-directed hplc

실험 절차

A solution of (R)-(1,1-dimethylethyl 2-{[(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)amino]methyl}-1-pyrrolidinecarboxylate in methanol was treated with a solution of hydrogen chloride in ether (1M). The resulting mixture was stirred 30 minutes then concentrated under vacuum and then loaded onto an ion-exchange cartridge (SCX-2) and eluted with methanol followed by ammonia in methanol (1 M). The combined basic fractions were concentrated under vacuum. The residue, (10 mg) was then dissolved in DCM (1 mL) and treated with triphosgene (23 mg, 0.3 eq.), diisopropylamine (4 uL, 3 eq.). The mixture was stirred for 1 h then concentrated under vacuum and purified by preparative mass-directed hplc to afford the title compound (3.1 mg).

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US07732600B2uspto-grants-2010_06